Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct;18(10):73.
doi: 10.1007/s11906-016-0682-1.

Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects

Affiliations
Review

Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects

Samuel J Jurca et al. Curr Hypertens Rep. 2016 Oct.

Abstract

Purpose of review: The purpose of this review is to highlight common or important substances or habits that elevate blood pressure and offer suggestions, based on recent literature, to limit their use or effects.

Recent findings: Despite decades of advice to the general populace from public health authorities to avoid or reduce dietary sodium and non-steroidal anti-inflammatory drug (NSAID) use, more evidence has accumulated from nationwide surveys, clinical trials, and pathophysiological or mechanistic studies that show how important these modalities can (and should) be for hypertensive and prehypertensive individuals and the general population. Other common stimuli that increase blood pressure can be divided into many that are easily avoided (e.g., phenethylamines, anabolic steroids), those that must be continued for important medical reasons (e.g., erythropoietin, tyrosine kinase inhibitors) and therefore require intensified antihypertensive therapy, and a few (e.g., glucocorticoids, hormonal contraceptives) that fall between these two paradigms.

Keywords: Blood pressure; Drug-induced hypertension; Resistant hypertension; Secondary hypertension.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 2014 Aug 28;371(9):818-27 - PubMed
    1. JAMA. 2003 May 14;289(18):2363-9 - PubMed
    1. Lancet. 2016 Apr 2;387(10026):1405-1414 - PubMed
    1. Neth J Med. 1995 Nov;47(5):230-4 - PubMed
    1. Hypertension. 2008 Jun;51(6):1403-19 - PubMed

MeSH terms

Substances

LinkOut - more resources